• MEBO联合西替利嗪治疗群体性日光性皮炎疗效观察
  • Curative Effect Observation in Treatment of Mass Solar Dermatitis with MEBO and Cetirizine
  • 张滨,房立新.MEBO联合西替利嗪治疗群体性日光性皮炎疗效观察[J].中国烧伤创疡杂志,2014,(3):213~215.
    DOI:
    中文关键词:  湿润烧伤膏  日光性皮炎  群体性  疗效
    英文关键词:MEBO, Solar Dermatitis, Mass, Curative Efficacy
    基金项目:
    作者单位
    张滨 解放军71799部队卫生队 
    房立新  
    摘要点击次数: 2810
    全文下载次数: 4987
    中文摘要:
          目的 探讨湿润烧伤膏(MEBO) 治疗日光性皮炎的临床疗效? 方法 将240例日光性皮炎患者分为治疗组(120例) 与对照组(120例), 两组患者均口服西替利嗪, 每日1次, 每次10mg? 治疗组创面局部应用MEBO暴露治疗, 对照组创面应用复方炉甘石洗剂治疗, 对比观察两组患者的有效率? 感染率及治愈时间?结果 治疗组患者有效率明显高于对照组(P<0.01), 感染率明显低于对照组(P<0.01), 治愈时间明显短于对照组(P<0.01)? 结论 MEBO治疗日光性皮炎的疗效优于复方炉甘石洗剂, 适用于海上群体日光性皮炎的治疗?
    英文摘要:
          Objective – To explore the clinical efficacy of MEBO in treating solar dermatitis. Method – A total of 240 patients with solar dermatitis were divided into two groups, the treatment group (120) and control group (120), which orally took Cetirizine once a day at the dosage of 10mg. The wounds in treatment group received exposed therapy of MEBO, and the control group was treated with compound calamine lotion. The effective rate, infection rate and healing time of the two groups were observed and compared. Result – Compared to control group, patients in treatment group had obviously higher effective rate (P<0.01), lower infection rate (P<0.01), and shorter healing time (P<0.01). Conclusion – MEBO is superior to compound calamine lotion in treating solar dermatitis, being suitable for treatment of offshore mass solar dermatitis.